Abstract
THE CURRENT ARMAMENTARIUM OF DRUGS FOR FIGHT AGAINST OBESITY

Anandabaskar Nishanthi*, Mourouguessine Vimal, Selvarajan Sandhiya and Steven Aibor Dkhar

ABSTRACT

Obesity is a condition characterized by the accumulation of excess body fat which endangers the health of an individual. It is associated with increased risk of co-morbidities like diabetes, hypertension, dyslipidemia and various cancers. Mounting evidence indicates that even a modest weight loss in obese patients would be hugely rewarding with substantial health benefits. Lifestyle modifications can produce only a small reduction in weight, and adherence to the regimen becomes poorer in long run. Thus, there is need for drugs which can augment the weight loss. At present, there is a dearth of anti-obesity drugs and the therapeutic options are limited. Till date, only five drugs are approved by the US FDA (United States Food and Drug Administration) for long term management of obesity, namely orlistat, lorcaserin, phentermine/topiramate, naltrexone/bupropion and liraglutide. This review discusses the various regulators of energy balance and appetite modulation, and highlights the salient features regarding the efficacy and safety of the current anti-obesity drugs. The data were obtained from articles present in databases of Medline and Google scholar.

Keywords: Obesity, weight reduction, appetite, pharmacotherapy, energy homeostasis.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW SEPTEMBER ISSUE PUBLISHED

    SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT